ClinicalTrialsFinder

Micropapillary Variant Urothelial Carcinoma (Favorable Subtype) Clinical Trials in Iowa City, Iowa

1 recruitingIowa City, Iowa

Showing 1–1 of 1 trials

Recruiting
Phase 2

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Urothelial CarcinomaBladder CancerNon-Muscle-Invasive Bladder Cancer (NMIBC)+8 more
Michael A. O'Donnell174 enrolled1 locationNCT07322263